#
Cefaclor Extended Release Tablets
  • Professionals
  • FDA PI

Cefaclor Extended Release Tablets

Dosage form: tablet, film coated, extended release
Drug class:Second generation cephalosporins

Medically reviewed by Drugs.com. Last updated on Jun 21, 2021.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefaclor extended-release tablets USP and other antibacterial drugs, cefaclor extended-release tablets USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Cefaclor Extended Release Tablets Description

Cefaclor, USP, the active ingredient in cefaclor extended-release tablets USP, is a semisynthetic cephalosporin antibiotic for oral administration. Cefaclor, USP, is chemically designated as 3-chloro-7-D­(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate. The cefaclor extended-release tablets formulation of cefaclor differs pharmacokinetically from the immediate-release formulation of cefaclor.

C15H14ClN3O

LEARN MORE ABOUT US
CONTACT INFORMATION

LINKS

MEDICAL DEPARTMENTS

Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram